IPO registrations (S-1, F-1) · Registrants
TransMedics Group, Inc.
- SEC CIK
- 1756262 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2019-04-05, last 2019-05-01; 1 initial registration, 3 amendments
- Outcome
- Final prospectus filed 2019-05-02; declared effective 2019-05-01
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- MA
- Business address
- 200 MINUTEMAN ROAD, Andover, MA 01810
- Ticker
- TMDX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- TransMedics Group, Inc. on the corporate pages
Offering terms
- Proposed price range
- $15.00–$17.00 per share (S-1/A filed 2019-05-01)
- Final price
- $16.00 per share, within the range (424B4 filed 2019-05-02, an initial public offering)
- Shares sold
- 5,690,000
- Gross proceeds
- $91,040,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TMDX
- Lead underwriters
- Morgan Stanley; J.P. Morgan
- Syndicate
- Cowen; Canaccord Genuity
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Lobbying client: TRANSMEDICS GROUP, INC. Fuzzy (name and state)
- SEC filer: TransMedics Group, Inc. EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-04-05 | S-1 | S-1 (registration) | TransMedics Group, Inc. | 0001193125-19-099213 ↗ |
| 2019-04-22 | S-1/A | S-1/A (amendment) | TransMedics Group, Inc. | 0001193125-19-112722 ↗ |
| 2019-04-30 | S-1/A | S-1/A (amendment) | TransMedics Group, Inc. | 0001193125-19-126462 ↗ |
| 2019-05-01 | S-1/A | S-1/A (amendment) | TransMedics Group, Inc. | 0001193125-19-130580 ↗ |
| 2019-05-01 | S-1MEF | S-1MEF (added securities) | TransMedics Group, Inc. | 0001193125-19-133517 ↗ |
| 2019-05-01 | EFFECT | EFFECT (declared effective) | TransMedics Group, Inc. | 9999999995-19-000980 ↗ |
| 2019-05-02 | 424B4 | 424B4 (final prospectus) | TransMedics Group, Inc. | 0001193125-19-135109 ↗ |
| 2020-05-21 | EFFECT | EFFECT (declared effective) | TransMedics Group, Inc. | 9999999995-20-001235 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-05-01 | S-1/A | registration statement | $15.00–$17.00 | 4,700,000 | - | Nasdaq TMDX | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2019-05-02 | 424B4 | final prospectus | $16.00 | 5,690,000 | $91,040,000 | Nasdaq TMDX | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ABRAMS CAPITAL, LLC | TenPercentOwner | 3 | 2019–2021 | ||
| ABRAMS CAPITAL MANAGEMENT, LLC | TenPercentOwner | 3 | 2019–2021 | ||
| ABRAMS CAPITAL MANAGEMENT, L.P. | TenPercentOwner | 3 | 2019–2021 | ||
| Abrams Capital Partners II, L.P. | TenPercentOwner | 3 | 2019–2021 | ||
| Abrams David C | TenPercentOwner | 3 | 2019–2021 | ||
| AFEYAN NOUBAR | TenPercentOwner | 3 | 2019 | ||
| Basile Edward M | Director | 20 | 2019–2026 | ||
| Carey John F | Officer | VP of Operations | 40 | 2019–2023 | |
| Flagship Ventures 2007 General Partner LLC | TenPercentOwner | 3 | 2019 | ||
| Flagship Ventures Fund 2007, L.P. | TenPercentOwner | 3 | 2019 | ||
| Flagship Ventures Fund IV General Partner LLC | TenPercentOwner | 3 | 2019 | ||
| Flagship Ventures Fund IV, L.P. | TenPercentOwner | 3 | 2019 | ||
| Gilbert James | Director | 1 | 2019 | ||
| Gordon Stephen | Officer | Chief Financial Officer | 37 | 2019–2024 | |
| Gunderson Thomas J. | Director | 10 | 2019–2026 | ||
| Hassanein Waleed H | Director,Officer | President & CEO | 53 | 2019–2026 | |
| Kania Edwin | Director | 13 | 2019–2026 | ||
| Khayal Tamer I | Officer | Chief Commercial Officer | 55 | 2019–2025 | |
| Lung Biotechnology PBC | TenPercentOwner | 3 | 2019 | ||
| Provost Miriam | Officer | VP, Global Regulatory Affairs; VP of Global Regl. Affairs; VP of US Regulatory & FDA Rel. | 14 | 2019–2023 | |
| Riva Capital Management III, LLC | TenPercentOwner | 3 | 2019–2021 | ||
| Riva Capital Partners III, L.P. | TenPercentOwner | 3 | 2019–2021 | ||
| Sullivan John F | Officer | VP of Quality & Engineering | 11 | 2019–2021 | |
| TOBIN JAMES R | Director | 22 | 2019–2026 | ||
| UNITED THERAPEUTICS Corp | TenPercentOwner | 3 | 2019 | ||
| Weill David | Director | 17 | 2019–2026 | ||
| DAMME LAURA | Officer | VP, Clinical Affairs | 7 | 2019–2023 | |
| RAINES MERILEE | Director | 8 | 2021–2026 | ||
| Lovell Stephanie | Director | 10 | 2021–2026 | ||
| Godhani Rakesh P. | Officer | Chief Digital Officer | 2 | 2021 | |
| Corcoran Nicholas | Officer | See remarks; See Remarks | 8 | 2023–2026 | |
| Ranganath Anil P. | Officer | See remarks; See Remarks | 7 | 2023–2026 | |
| Hernandez Gerardo | Officer | Chief Financial Officer | 6 | 2024–2026 | |
| Cecere Giovanni | Officer | Chief Commercial Officer | 3 | 2026 | |
| Forsyth Matthew S. | Officer | See Remarks | 2 | 2026 | |
| Araujo Fernando N. | Officer | See Remarks | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| IPO registrant | TransMedics, Inc. | MA | IPO registrations (S-1, F-1) | same street address and ZIP code, 200 MINUTEMAN RD 01810 (FUZZY: a shared address, not proof of a shared organization) |
| Lobbying client | TRANSMEDICS GROUP, INC. | MA | Federal lobbying (LDA) | name and state |
| SEC filer | TransMedics Group, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Electromedical & Electrotherapeutic Apparatus, MA first:
- VIKING SYSTEMS INC MA
- TransMedics, Inc. MA
- INFRAREDX INC MA
- Mevion Medical Systems, Inc. MA
- NxStage Medical, Inc. MA
- Candela Medical, Inc. MA
- CANDELA CORP /DE/ MA
- PRECISION OPTICS CORPORATION, INC. MA
- CYNOSURE INC MA
- ASPECT MEDICAL SYSTEMS INC MA
In other datasets, the same topic (Technology) in MA:
- Form D issuer: 10 Percent Happier, Inc. (Form D private offerings)
- Lobbying client: 5G ACTION NOW (Federal lobbying (LDA))
Interests: Electromedical & Electrotherapeutic Apparatus · Technology